Navigation Links
Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
Date:10/8/2007

ere 3.5 times more frequent, and gastrointestinal symptoms, which were 1.5 to 2 times more frequent. Urinary tract disorders and menopausal symptoms were also recorded twice as frequently among the women in the ovarian cancer group.

This study found that while the presence of ovarian cancer-related symptoms and conditions prior to diagnoses was documented in the medical claims data, this increase was most pronounced in the two to three months prior to diagnosis. Still, there remains a challenge to link symptoms with ovarian cancer, as many of the related symptoms are also present for several other disorders and diseases.

"Ovarian cancer is most often diagnosed at the later stages," said Stella Chang, research director at Thomson Healthcare and co-author of the study. "Identifying a pattern of symptoms can keep doctors one step ahead of a dangerous disease. It is important to understand that these symptoms do not automatically dictate that a woman has ovarian cancer, but recognizing them could lead to earlier diagnosis and more treatment options to save a patient's life."

About the Study

The study, "Temporal Patterns of Conditions and Symptoms Potentially Associated with Ovarian Cancer," was conducted by the Centers for Disease Control and Prevention and Thomson Healthcare. It is published in the September issue of the Journal of Women's Health (Volume 16, Number 7, pp. 971-986.)

The authors are Michelle Wynn, formerly of the Centers for Disease Control and Prevention, Division of Cancer Prevention and Control; Stella Chang of Thomson Healthcare; and Lucy Peipins of the Centers for Disease Control and Prevention, Division of Cancer Prevention and Control.

About Thomson Healthcare

Thomson Healthcare is the leading provider of decision support solutions that help organizations across the healthcare industry improve clinical and business performance. Thomson Healthcare products and services help clinicians, hospitals, employers,
'/>"/>

SOURCE Thomson Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Iron supplementation for a common side effect
3. Genetic Breakthrough in Common Eye Problem
4. Common Cold Found to Fight Cancer Cells
5. Side Effects Of Some Common Drugs
6. E. coli strains resistant to a common antibiotic
7. Gastrointestinal ills more common in diabetics
8. Toxic effects common with AIDS treatments
9. Common contraception
10. Drooping eyelids more common in men
11. Unnatural death common in mentally ill
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 2Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 4Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 5Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 6Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 7Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 8Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 9Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 2Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 4Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 5Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 6Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 2Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 3